Publications

Export 6045 results:
Sort by: Author [ Title  (Desc)] Type Year
A B C [D] E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
D
Al-Kubaisi, N. J., H. Said, and N. A. Horeesh, "Death certification practice in Qatar", p u b l i c health, issue 127, pp. 8 5 4e8 5 9, 2013. death_certification_practice_in_qatar.pdf
Mostafa, Y. S. E. D., "Dealing with capsules", 13 th International conference of Jordianan Ophthalmological society, Amman , Jordan, 15 september, 2017.
Alsirafy, S. A., "Dealing with barriers to cancer pain control in Egypt", European Journal of Palliative Care, vol. 17, no. 1, pp. 10-11, 2010. Abstract

n/a

H.Hassan, S., L. H. Ahmed, and A. A. Badr, "Deadlock Detection and Recovery in P systems", International Journal of Computer Applications, vol. 92, issue 10, 2013.
S.Hesham, L.H.Ahmed, and A.Badr, "Deadlock Detection and Recovery in P Systems", International Journal of Computer Applications, vol. 92, 2014. Abstract

A P system is a computational model in computer science abstracted from the structure of real living cell that preforms some calculations under a certain conditions. They are distributed, parallel and run in a non-deterministic manner. This paper presents a model for solving the deadlock that could be happen between P system membranes. The P system model of degree n is used to simulate the deadlock that could be happen and the procedure of detecting the deadlock and removing it by triggering set of rules to interfere and solve the deadlock instead of killing the rules that cause the deadlock.

Saroit, I. A., "Deadlock Avoidance in Store-and-Forward Computer Networks", Scientific Bulletin of the Faculty of Engineering Ain Shams University, vol. 32, 1997.
Bayoumi, E., M. Soliman, and H. M. Soliman, "Deadbeat PQ Control for Islanded Smart Grids", European Journal of Electrical Engineering and Computer Science , vol. 4, issue 5, 2020.
Bayoumi, E. H. E., M. Awadallah, and H. Soliman, "Deadbeat Performance of Vector-Controlled Induction Motor Drives Using Particle Swarm Optimization and Adaptive Neuro-Fuzzy Inference Systems", Electromotion Scientific Journal, vol. 18, issue 4, pp. 231 - 242, 2011. Abstractcu_pdf.pdf

The paper presents a design technique for adaptive PI current and speed controllers maintaining deadbeat response in vector-controlled induction motor drives. The proposed design is based on particle swarm optimization (PSO) and adaptive neuro-fuzzy inference systems (ANFIS).

E.H.E.Bayoumi, M. A. Awadallah, and H. M. Soliman, "Deadbeat performance of vector-controlled induction motor drives using particle swarm optimization and adaptive neuro-fuzzy inference systems", ELECTROMOTION , vol. 18, pp. 231-242, 2011.
El-Daleel, M. S., O. Mahgoub, A. L. Elshafie, and A. Mahgoub, "Dead-time compensation via adaptive lookup table reconstruction for low-speed operation", 9th IEEE International Conference on Power Electronics, Drives and Energy Systems, PEDES 2020, Jaipur, India, 16-19 Dec., 2020.
El-Daleel, M. S., O. Mahgoub, A. L. Elshafie, and A. Mahgoub, "Dead-time Compensation via Adaptive Lookup Table Reconstruction for Low-Speed Operation", 2020 IEEE International Conference on Power Electronics, Drives and Energy Systems (PEDES), pp. 1 - 6, 16-19 Dec. 2020. Abstract

n/a

Ouannas, A., G. Grassi, A. T. Azar, A. G. Radwan, C. Volos, V. - T. Pham, T. Ziar, I. M. Kyprianidis, and I. N. Stouboulos, "Dead-beat synchronization control in discrete-time chaotic systems", Modern Circuits and Systems Technologies (MOCAST), 2017 6th International Conference on: IEEE, pp. 1–4, 2017. Abstract
n/a
El-Zawawy, M. A., "Dead code elimination based pointer analysis for multithreaded programs", Journal of the Egyptian Mathematical Society, vol. 20, no. 1, pp. 28-37, January, 2012. AbstractDead code elimination based pointer analysis for multithreaded programs.pdf

This paper presents a new approach for optimizing multitheaded programs with pointer constructs. The approach has applications in the area of certified code (proof-carrying code) where a justification or a proof for the correctness of each optimization is required. The optimization meant here is that of dead code elimination. Towards optimizing multithreaded programs the paper presents a new operational semantics for parallel constructs like join-fork constructs, parallel loops, and conditionally spawned threads. The paper also presents a novel type system for flow-sensitive pointer analysis of multithreaded programs. This type system is extended to obtain a new type system for live-variables analysis of multithreaded programs. The live-variables type system is extended to build the third novel type system, proposed in this paper, which carries the optimization of dead code elimination. The justification mentioned above takes the form of type derivation in our approach.

Abdel-Mageed, A. M., D. Widmann, S. E. Olesen, I. Chorkendorff, and J. R. Behm, "Deactivation of supported Ru catalysts during the Selective CO Methanation (SelMeth): Separating structural and adlayer effects ", Chemical Reactions at Surfaces, (GRS) Gordon Research Seminar, Renaissance Tuscany Il Ciocco Lucca (Barga), Italy, 04.02.2017. jrs_deactivation_of_supported_ru_catalysts.pdf
El-Moemen, A. A., A. M. Abdel-Mageed, M. Parlinska-Wojtan, R. J. Behm, and G. Kučerová, "Deactivation of Au/CeO 2 catalysts during CO oxidation: Influence of pretreatment and reaction conditions", Journal of Catalysis, vol. 341, pp. 160-179, 2016.
Galal, S. M., "Deacidification of lampante olive oil", Egyptian J. of Nutrition, vol. 23, no. 2: The Egyptian Nutrition Society, pp. 133–156, 2008. Abstract
n/a
Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, H. I. Shousha, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.", European journal of gastroenterology & hepatology, vol. 30, issue 1, pp. 39-43, 2018 Jan. Abstract

INTRODUCTION: A recent appearance of direct-acting antivirals (DAAs) led to a surge in hepatitis C virus (HCV) management. Nowadays, a large proportion of treated patients have cirrhosis with a retained possibility to develop hepatocellular carcinoma (HCC) even after complete cure. We aimed to study tumoral differences between patients who developed HCC after DAAs as either a recurrence or de-novo HCC.

METHODS: We retrospectively analyzed 89 patients who presented to our HCC multidisciplinary clinic with HCC lesions following DAA therapy. A total of 45 patients had complete response to HCC according to the modified Response Evaluation Criteria in Solid Tumors before DAAs intake. Another 44 patients developed de-novo lesions after DAA treatment. Both groups were compared regarding their baseline characteristics, tumor criteria, response to DAAs as well response to HCC treatment.

RESULTS: Both groups showed no significant difference regarding their baseline characteristics (age, sex, Child-Pugh score, and performance status) or response to DAAs (P=0.5). No significant difference was present between groups according to number, site, and size of lesions. However, time elapsed between the end of DAAs therapy and first diagnosis of HCC was significantly longer in de-novo group (15.22±16.39 months) versus recurrence group (6.76±5.1 months) (P=0.008). In addition, response to ablation was significantly better in de-novo lesions compared with recurrent HCC (P=0.03).

CONCLUSIONS: Although de-novo HCC lesions significantly developed later than recurrent lesions in DAAs-treated patients, their response rates were significantly better. No differences were detected between both groups in their response to DAAs and their tumoral characteristics.

Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, H. I. Shousha, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.", European journal of gastroenterology & hepatology, vol. 30, issue 1, pp. 39-43, 2018 Jan. Abstract

INTRODUCTION: A recent appearance of direct-acting antivirals (DAAs) led to a surge in hepatitis C virus (HCV) management. Nowadays, a large proportion of treated patients have cirrhosis with a retained possibility to develop hepatocellular carcinoma (HCC) even after complete cure. We aimed to study tumoral differences between patients who developed HCC after DAAs as either a recurrence or de-novo HCC.

METHODS: We retrospectively analyzed 89 patients who presented to our HCC multidisciplinary clinic with HCC lesions following DAA therapy. A total of 45 patients had complete response to HCC according to the modified Response Evaluation Criteria in Solid Tumors before DAAs intake. Another 44 patients developed de-novo lesions after DAA treatment. Both groups were compared regarding their baseline characteristics, tumor criteria, response to DAAs as well response to HCC treatment.

RESULTS: Both groups showed no significant difference regarding their baseline characteristics (age, sex, Child-Pugh score, and performance status) or response to DAAs (P=0.5). No significant difference was present between groups according to number, site, and size of lesions. However, time elapsed between the end of DAAs therapy and first diagnosis of HCC was significantly longer in de-novo group (15.22±16.39 months) versus recurrence group (6.76±5.1 months) (P=0.008). In addition, response to ablation was significantly better in de-novo lesions compared with recurrent HCC (P=0.03).

CONCLUSIONS: Although de-novo HCC lesions significantly developed later than recurrent lesions in DAAs-treated patients, their response rates were significantly better. No differences were detected between both groups in their response to DAAs and their tumoral characteristics.

Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, H. I. Shousha, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.", European journal of gastroenterology & hepatology, vol. 30, issue 1, pp. 39-43, 2018. Abstract

INTRODUCTION: A recent appearance of direct-acting antivirals (DAAs) led to a surge in hepatitis C virus (HCV) management. Nowadays, a large proportion of treated patients have cirrhosis with a retained possibility to develop hepatocellular carcinoma (HCC) even after complete cure. We aimed to study tumoral differences between patients who developed HCC after DAAs as either a recurrence or de-novo HCC.

METHODS: We retrospectively analyzed 89 patients who presented to our HCC multidisciplinary clinic with HCC lesions following DAA therapy. A total of 45 patients had complete response to HCC according to the modified Response Evaluation Criteria in Solid Tumors before DAAs intake. Another 44 patients developed de-novo lesions after DAA treatment. Both groups were compared regarding their baseline characteristics, tumor criteria, response to DAAs as well response to HCC treatment.

RESULTS: Both groups showed no significant difference regarding their baseline characteristics (age, sex, Child-Pugh score, and performance status) or response to DAAs (P=0.5). No significant difference was present between groups according to number, site, and size of lesions. However, time elapsed between the end of DAAs therapy and first diagnosis of HCC was significantly longer in de-novo group (15.22±16.39 months) versus recurrence group (6.76±5.1 months) (P=0.008). In addition, response to ablation was significantly better in de-novo lesions compared with recurrent HCC (P=0.03).

CONCLUSIONS: Although de-novo HCC lesions significantly developed later than recurrent lesions in DAAs-treated patients, their response rates were significantly better. No differences were detected between both groups in their response to DAAs and their tumoral characteristics.

Abdelaziz, A. O., M. M. Nabi, A. H. Abdelmaksoud, H. I. Shoushaa, A. A. Cordie, E. M. Hassan, D. A. Omran, R. Leithy, and T. M. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus", European Journal of Gastroenterology & Hepatology, vol. 30, issue 1, pp. 39–43, 2018.
Abdelaziz, A. O., M. M. Nabil, A. H. Abdelmaksoud, and T. Elbaz, "De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus", European Journal of Gastroenterology and Hepatology, vol. 30, issue 1, pp. 39-43, 2018.
Geraniotis, E., and M. M. Khairy, De-modulation of MOK (M-ary orthogonal modulation), , 2005. Abstract
n/a
Geraniotis, E., and M. M. Khairy, De-modulation of MOK (M-ary orthogonal modulation), , 2007. Abstract
n/a
Tourism